meglumine has been researched along with bilirubin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Abahussain, A; al-Gindan, Y; alKhawajah, A; Jain, S; Larbi, EB | 1 |
| Blumenfield, DM; Blumetti, RF; Goldstein, HA; Holyoak, WL; Hugo, FP; Kashanian, FK | 1 |
| Niendorf, HP; Seifert, W | 1 |
| Berman, JD; Hanson, WL; Keenan, CM; Lamb, SR; Waits, VB | 1 |
| de Haën, C; Lorusso, V; Luzzani, F; Tirone, P | 1 |
| Anelli, PL; Cupelli, F; Lorusso, V; Pascolo, L; Tiribelli, C; Uggeri, F; Visigalli, M | 1 |
| Cha, SW; Kim, H; Kim, KW; Kim, MJ; Lim, JS; Park, MS; Yoo, HS | 1 |
| Hou, FQ; Qian, JD; Shao, C; Wang, GQ; Wang, TL | 1 |
| Antonova, EA; Belikova, TN; Kovalenko, AL; Morozov, VG; Popova, VB; Rafalskiy, VV; Stel'makh, VV; Uspenskiy, YP | 1 |
3 trial(s) available for meglumine and bilirubin
| Article | Year |
|---|---|
Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
Topics: Bilirubin; Clinical Trials as Topic; Contrast Media; Drug Combinations; Electrocardiography; Electroencephalography; Gadolinium; Gadolinium DTPA; Headache; Humans; Iron; Magnetic Resonance Imaging; Meglumine; Nausea; Organometallic Compounds; Paresthesia; Pentetic Acid; Research Design; Sorbitol; United States | 1990 |
Serum iron and serum bilirubin after administration of Gd-DTPA-dimeglumine. A pharmacologic study in healthy volunteers.
Topics: Adult; Bilirubin; Contrast Media; Drug Combinations; Gadolinium DTPA; Humans; Iron; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Random Allocation; Sorbitol | 1988 |
[The results of phase III multicenter open randomized controlled study REM-Chol-III-16 in patients with intrahepatic cholestasis syndrome caused by chronic diffuse liver diseases].
Topics: Alkaline Phosphatase; Bilirubin; Cholestasis, Intrahepatic; gamma-Glutamyltransferase; Humans; Inosine; Meglumine; Methionine; Niacinamide; S-Adenosylmethionine; Succinic Acid; Transaminases | 2021 |
6 other study(ies) available for meglumine and bilirubin
| Article | Year |
|---|---|
Subacute toxicity of pentavalent antimony compounds in rats.
Topics: Alkaline Phosphatase; Animals; Antimony; Antimony Sodium Gluconate; Behavior, Animal; Bilirubin; Blood Cell Count; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Female; Hemoglobins; Kidney; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rats; Weight Gain | 1992 |
Leishmania donovani: oral efficacy and toxicity of formycin B in the infected hamster.
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Antimony; Bilirubin; Bone Marrow; Cricetinae; Drug Evaluation, Preclinical; Formycins; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds | 1983 |
Hepatic transport of the magnetic resonance imaging contrast agent gadobenate dimeglumine in the rat.
Topics: Analysis of Variance; Animals; Bilirubin; Biological Transport; Contrast Media; Liver; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 1995 |
Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents.
Topics: Animals; Anion Transport Proteins; Bilirubin; Binding, Competitive; Biological Transport; Carrier Proteins; Cell Membrane; Contrast Media; Gadolinium DTPA; Humans; Kinetics; Liver; Magnetic Resonance Imaging; Meglumine; Oocytes; Organometallic Compounds; Osmolar Concentration; Rats; RNA, Messenger; Sulfobromophthalein; Taurocholic Acid; Xenopus laevis | 1999 |
Potential conditions causing impairment of selective hepatobiliary enhancement of gadobenate dimeglumine-enhanced delayed magnetic resonance imaging.
Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Biliary Tract; Bilirubin; Blood Urea Nitrogen; Contrast Media; Creatinine; Female; Humans; Image Enhancement; Kidney Diseases; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Retrospective Studies; Splenomegaly | 2010 |
Gilbert syndrome combined with prolonged jaundice caused by contrast agent: Case report.
Topics: Adult; Bilirubin; Biopsy; Cholangiopancreatography, Endoscopic Retrograde; Cholangiopancreatography, Magnetic Resonance; Choledocholithiasis; Contrast Media; Gilbert Disease; Humans; Iohexol; Jaundice, Obstructive; Liver; Liver Function Tests; Male; Meglumine; Organometallic Compounds; Remission, Spontaneous | 2018 |